Merck KGaA (OTCMKTS:MKKGY) Sees Strong Trading Volume – Still a Buy?

Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw an uptick in trading volume on Monday. 537,087 shares were traded during mid-day trading, an increase of 470% from the average daily volume of 94,300 shares. The stock last traded at $32.88 and had previously closed at $33.07.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Zacks Research upgraded Merck KGaA from a “strong sell” rating to a “hold” rating in a report on Tuesday, November 10th. UBS Group downgraded Merck KGaA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 20th. Six equities research analysts have rated the stock with a Hold rating. According to MarketBeat, the company has an average rating of “Hold”.

Check Out Our Latest Stock Analysis on MKKGY

Merck KGaA Stock Performance

The firm has a 50-day moving average of $31.80 and a 200-day moving average of $30.12. The company has a current ratio of 1.69, a quick ratio of 1.09 and a debt-to-equity ratio of 0.37. The stock has a market capitalization of $21.31 billion, a price-to-earnings ratio of 24.07, a P/E/G ratio of 2.62 and a beta of 0.92.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA is a German science and technology company headquartered in Darmstadt. Founded in 1668, it traces its origins to a pharmacy established by the Merck family and has grown into a global business serving customers in healthcare, research and industry. It is separate from the U.S.-based Merck & Co. The company operates through three main businesses. Its Healthcare division develops and markets prescription medicines, including treatments in areas such as oncology, neurology and fertility.

See Also

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.